| scholarly article | Q13442814 |
| P50 | author | Jeong-sun Ju | Q42890615 |
| Rodrigo A Fuentealba | Q56380752 | ||
| Robert H Baloh | Q88414299 | ||
| Conrad C Weihl | Q114404424 | ||
| David Piwnica-Worms | Q124025940 | ||
| P2093 | author name string | Sara E Miller | |
| Erin Jackson | |||
| P2860 | cites work | GATE-16, a membrane transport modulator, interacts with NSF and the Golgi v-SNARE GOS-28 | Q22253422 |
| Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes | Q23757358 | ||
| Phosphatidylserine in addition to phosphatidylethanolamine is an in vitro target of the mammalian Atg8 modifiers, LC3, GABARAP, and GATE-16 | Q24296712 | ||
| Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice | Q24303752 | ||
| Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia | Q24309521 | ||
| p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy | Q24312147 | ||
| Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis | Q24642141 | ||
| Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability | Q24648173 | ||
| The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol | Q27936514 | ||
| RETRACTED: VMA21 deficiency causes an autophagic myopathy by compromising V-ATPase activity and lysosomal acidification | Q28115568 | ||
| Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q28131672 | ||
| Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice | Q28131756 | ||
| Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation | Q28247784 | ||
| UBX domain proteins: major regulators of the AAA ATPase Cdc48/p97 | Q28277816 | ||
| Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation | Q28284708 | ||
| Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3 | Q29614176 | ||
| FoxO3 controls autophagy in skeletal muscle in vivo | Q29614483 | ||
| Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein | Q29619232 | ||
| VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death | Q30487226 | ||
| Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). | Q33916484 | ||
| Quantitation of selective autophagic protein aggregate degradation in vitro and in vivo using luciferase reporters. | Q34355428 | ||
| Distinct roles for the AAA ATPases NSF and p97 in the secretory pathway | Q35799558 | ||
| Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease | Q36119653 | ||
| Sequential SNARE disassembly and GATE-16-GOS-28 complex assembly mediated by distinct NSF activities drives Golgi membrane fusion | Q36324604 | ||
| Electron microscopy in neuromuscular disorders | Q36326526 | ||
| p97: The cell's molecular purgatory? | Q36515839 | ||
| Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/VCP-associated disease | Q36949378 | ||
| Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease | Q37089630 | ||
| Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone | Q37217673 | ||
| Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia | Q37452177 | ||
| Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. | Q39878605 | ||
| The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy | Q40157250 | ||
| TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia | Q41667459 | ||
| The first molecular evidence that autophagy relates rimmed vacuole formation in chloroquine myopathy | Q41917623 | ||
| Amyloid-beta accumulation caused by chloroquine injections precedes ER stress and autophagosome formation in rat skeletal muscle | Q41939196 | ||
| Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1. | Q41997710 | ||
| Exocytotic “constipation” is a mechanism of tubulin/lysosomal interaction in colchicine myopathy | Q44410422 | ||
| RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis | Q44681202 | ||
| Mutant valosin-containing protein causes a novel type of frontotemporal dementia | Q45283163 | ||
| p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis. | Q45967668 | ||
| In search of an "autophagomometer". | Q46027342 | ||
| TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations | Q48284829 | ||
| Pathological consequences of VCP mutations on human striated muscle | Q48418017 | ||
| Valosin-containing protein gene mutations: clinical and neuropathologic features | Q48491139 | ||
| Phosphorylation-dependent TDP-43 antibody detects intraneuronal dot-like structures showing morphological characters of granulovacuolar degeneration | Q48562879 | ||
| Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice. | Q50471241 | ||
| An Italian family with inclusion-body myopathy and frontotemporal dementia due to mutation in the VCP gene. | Q53531100 | ||
| Involvement of valosin-containing protein (VCP)/p97 in the formation and clearance of abnormal protein aggregates. | Q53545034 | ||
| Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations | Q79749230 | ||
| TDP-43 accumulation is common in myopathies with rimmed vacuoles | Q82886837 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autophagy | Q288322 |
| P304 | page(s) | 875-888 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Journal of Cell Biology | Q1524550 |
| P1476 | title | Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease | |
| P478 | volume | 187 |
| Q37610585 | "Get the Balance Right": Pathological Significance of Autophagy Perturbation in Neuromuscular Disorders |
| Q46501146 | 215th ENMC International Workshop VCP-related multi-system proteinopathy (IBMPFD) 13-15 November 2015, Heemskerk, The Netherlands |
| Q27931659 | A Cdc48p-associated factor modulates endoplasmic reticulum-associated degradation, cell stress, and ubiquitinated protein homeostasis |
| Q37404484 | A Dynamic molecular basis for malfunction in disease mutants of p97/VCP. |
| Q28546097 | A Fine Balance of Dietary Lipids Improves Pathology of a Murine Model of VCP-Associated Multisystem Proteinopathy |
| Q33790385 | A Mighty "Protein Extractor" of the Cell: Structure and Function of the p97/CDC48 ATPase |
| Q23757242 | A comprehensive glossary of autophagy-related molecules and processes (2nd edition) |
| Q35976721 | A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseases |
| Q37465815 | A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas. |
| Q35194634 | A network of RNA and protein interactions in Fronto Temporal Dementia |
| Q28596603 | A non-canonical role of the p97 complex in RIG-I antiviral signaling |
| Q28115494 | A novel mutation in VCP causes Charcot-Marie-Tooth Type 2 disease |
| Q36565507 | A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse |
| Q36438451 | AAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization. |
| Q37665634 | AAA-ATPase p97 suppresses apoptotic and autophagy-associated cell death in rheumatoid arthritis synovial fibroblasts. |
| Q49608524 | Ageing as a risk factor for ALS/FTD. |
| Q36554939 | Airway Exposure to E-Cigarette Vapors Impairs Autophagy and Induces Aggresome Formation |
| Q27680547 | Altered Intersubunit Communication Is the Molecular Basis for Functional Defects of Pathogenic p97 Mutants |
| Q28258936 | Altered cofactor regulation with disease-associated p97/VCP mutations |
| Q38314711 | Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken. |
| Q56531747 | Amyotrophic lateral sclerosis |
| Q38148471 | Amyotrophic lateral sclerosis: an update on recent genetic insights |
| Q34616336 | An investigation of the molecular mechanisms engaged before and after the development of Alzheimer disease neuropathology in Down syndrome: a proteomics approach |
| Q39449810 | Another VCP interactor: NF is enough |
| Q35164493 | Autophagic vacuolar pathology in desminopathies |
| Q28084804 | Autophagosome dynamics in neurodegeneration at a glance |
| Q50849295 | Autophagy and proteasome interconnect to coordinate cross-presentation through MHC class I pathway in B cells. |
| Q37247593 | Autophagy and ubiquitin-proteasome system contribute to sperm mitophagy after mammalian fertilization |
| Q52329270 | Autophagy as a common pathway in amyotrophic lateral sclerosis. |
| Q39335586 | Autophagy as an Emerging Common Pathomechanism in Inherited Peripheral Neuropathies |
| Q38264793 | Autophagy in neuronal cells: general principles and physiological and pathological functions |
| Q34119935 | Autophagy protects C. elegans against necrosis during Pseudomonas aeruginosa infection |
| Q53162347 | Autophagy: a new player in skeletal maintenance? |
| Q36816531 | Beyond antioxidant genes in the ancient Nrf2 regulatory network. |
| Q28659840 | Boning up on autophagy: the role of autophagy in skeletal biology |
| Q27303589 | Cardiac-Restricted Expression of VCP/TER94 RNAi or Disease Alleles Perturbs Drosophila Heart Structure and Impairs Function. |
| Q48265316 | Causative Genes in Amyotrophic Lateral Sclerosis and Protein Degradation Pathways: a Link to Neurodegeneration. |
| Q55410212 | Cdc48 and ubiquilins confer selective anterograde protein sorting and entry into the multivesicular body in yeast. |
| Q41628346 | Cdc48-independent proteasomal degradation coincides with a reduced need for ubiquitylation |
| Q27936229 | Cdc48/p97 and Shp1/p47 regulate autophagosome biogenesis in concert with ubiquitin-like Atg8 |
| Q27939735 | Cdc48/p97 promotes degradation of aberrant nascent polypeptides bound to the ribosome |
| Q47222331 | Chaperone-Mediated Regulation of Choline Acetyltransferase Protein Stability and Activity by HSC/HSP70, HSP90, and p97/VCP. |
| Q43488914 | Characterization of the Asian myopathy patients with VCP mutations |
| Q37619548 | Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias |
| Q28266780 | Control of p97 function by cofactor binding |
| Q26863439 | Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis |
| Q28295447 | Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death |
| Q37547167 | De novo prion aggregates trigger autophagy in skeletal muscle |
| Q35532028 | Decreases in valosin-containing protein result in increased levels of tau phosphorylated at Ser262/356. |
| Q34256709 | Derlin-1 regulates mutant VCP-linked pathogenesis and endoplasmic reticulum stress-induced apoptosis |
| Q37599978 | Disease mutations in the prion-like domains of hnRNPA1 and hnRNPA2/B1 introduce potent steric zippers that drive excess RNP granule assembly. |
| Q27026848 | Does a loss of TDP-43 function cause neurodegeneration? |
| Q37336130 | Drosophila clueless is involved in Parkin-dependent mitophagy by promoting VCP-mediated Marf degradation |
| Q47933386 | Dsc E3 ligase localization to the Golgi requires the ATPase Cdc48 and cofactor Ufd1 for activation of sterol regulatory element-binding protein in fission yeast. |
| Q47946104 | Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder. |
| Q21285051 | Dysregulation of the autophagy-endolysosomal system in amyotrophic lateral sclerosis and related motor neuron diseases |
| Q37350979 | Elevated O-GlcNAcylation of Extracellular Vesicle Proteins Derived from Metastatic Colorectal Cancer Cells |
| Q38974926 | Emerging connections between RNA and autophagy. |
| Q28258706 | Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system |
| Q30179386 | Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations |
| Q24631513 | Exome sequencing reveals VCP mutations as a cause of familial ALS |
| Q51016978 | FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. |
| Q37735987 | Fighting disease by selective autophagy of aggregate-prone proteins |
| Q27015865 | From neurodevelopment to neurodegeneration: the interaction of neurofibromin and valosin-containing protein/p97 in regulation of dendritic spine formation |
| Q35117475 | Gene expression profiling in tibial muscular dystrophy reveals unfolded protein response and altered autophagy. |
| Q46046794 | Genotype-phenotype study in patients with VCP valosin-containing protein mutations associated with multisystem proteinopathy. |
| Q36034366 | Global gene profiling of VCP-associated inclusion body myopathy |
| Q22676705 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) |
| Q41666716 | Hepatic cytochromes P450: structural degrons and barcodes, posttranslational modifications and cellular adapters in the ERAD-endgame |
| Q92266550 | Heterozygous mutations in valosin-containing protein (VCP) and resistance to VCP inhibitors |
| Q47110757 | Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma |
| Q36170792 | IBMPFD Disease-Causing Mutant VCP/p97 Proteins Are Targets of Autophagic-Lysosomal Degradation |
| Q55312826 | Identification of the CFTR c.1666A>G Mutation in Hereditary Inclusion Body Myopathy Using Next-Generation Sequencing Analysis. |
| Q24307689 | Imbalances in p97 co-factor interactions in human proteinopathy |
| Q34979278 | Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant |
| Q26766040 | Impaired Autophagy and Defective Mitochondrial Function: Converging Paths on the Road to Motor Neuron Degeneration |
| Q34086965 | Impaired autophagy in sporadic inclusion-body myositis and in endoplasmic reticulum stress-provoked cultured human muscle fibers |
| Q89658236 | Implications of Selective Autophagy Dysfunction for ALS Pathology |
| Q52308084 | In Search of a Cure for Proteostasis-Addicted Cancer: A AAA Target Revealed. |
| Q46148248 | In vitro studies in VCP-associated multisystem proteinopathy suggest altered mitochondrial bioenergetics |
| Q27346679 | Inactivation of VCP/ter94 suppresses retinal pathology caused by misfolded rhodopsin in Drosophila |
| Q36485185 | Inadequate fine-tuning of protein synthesis and failure of amino acid homeostasis following inhibition of the ATPase VCP/p97 |
| Q33871338 | Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy |
| Q43821019 | Increased autophagy accelerates colchicine-induced muscle toxicity |
| Q46130063 | Indications for a genetic association of a VCP polymorphism with the pathogenesis of sporadic Paget's disease of bone, but not for TNFSF11 (RANKL) and IL-6 polymorphisms |
| Q42030945 | Inhibition of autophagy, lysosome and VCP function impairs stress granule assembly |
| Q36078289 | Inhibitors of the AAA+ chaperone p97 |
| Q26851967 | Insights into muscle degeneration from heritable inclusion body myopathies |
| Q37333755 | Interaction between salt-inducible kinase 2 (SIK2) and p97/valosin-containing protein (VCP) regulates endoplasmic reticulum (ER)-associated protein degradation in mammalian cells |
| Q34074385 | Interaction with polyglutamine aggregates reveals a Q/N-rich domain in TDP-43. |
| Q47108927 | Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease? |
| Q37572116 | Lipid-enriched diet rescues lethality and slows down progression in a murine model of VCP-associated disease |
| Q28854599 | Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death |
| Q58772499 | Loss of the novel Vcp (valosin containing protein) interactor Washc4 interferes with autophagy-mediated proteostasis in striated muscle and leads to myopathy in vivo |
| Q28585799 | Lysosome size, motility and stress response regulated by fronto-temporal dementia modifier TMEM106B |
| Q30367534 | Macrolide Antibiotics Exhibit Cytotoxic Effect under Amino Acid-Depleted Culture Condition by Blocking Autophagy Flux in Head and Neck Squamous Cell Carcinoma Cell Lines |
| Q37929017 | Making connections: pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia. |
| Q38260329 | Mechanism and Regulation of Autophagy and Its Role in Neuronal Diseases |
| Q38796472 | Mechanisms of neuronal homeostasis: Autophagy in the axon |
| Q61718173 | Mechanisms of selective autophagy and mitophagy: Implications for neurodegenerative diseases. |
| Q90499172 | Membrane proteomic analysis reveals the intestinal development is deteriorated by intrauterine growth restriction in piglets |
| Q94595295 | Mendelian neurodegenerative disease genes involved in autophagy |
| Q28513331 | Mice deficient in Epg5 exhibit selective neuronal vulnerability to degeneration |
| Q30543660 | Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons |
| Q38038228 | Modulating macroautophagy: a neuronal perspective |
| Q38081388 | Monitoring autophagy in the treatment of protein aggregate diseases: steps toward identifying autophagic biomarkers |
| Q28080241 | Mutations in the Human AAA+ Chaperone p97 and Related Diseases |
| Q64119822 | Myo-granules Connect Physiology and Pathophysiology |
| Q33757336 | Myogenic differentiation of VCP disease-induced pluripotent stem cells: A novel platform for drug discovery |
| Q33947263 | Myopathy-causing mutations in an HSP40 chaperone disrupt processing of specific client conformers. |
| Q34592532 | Neuronal remodeling and apoptosis require VCP-dependent degradation of the apoptosis inhibitor DIAP1. |
| Q37062875 | Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice. |
| Q88250882 | New Developments in the Genetics of Inclusion Body Myositis |
| Q37748586 | New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis. |
| Q43197072 | New thoughts regarding Atg8 and ubiquitination |
| Q34535785 | Novel GNE mutations in two phenotypically distinct HIBM2 patients |
| Q36605617 | Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis |
| Q37786521 | Novel therapeutic approaches for inclusion body myositis. |
| Q42152336 | O-GlcNAc-modification of SNAP-29 regulates autophagosome maturation |
| Q91825235 | Oxidation and alkylation stresses activate ribosome-quality control |
| Q64779288 | PINK1 Interacts with VCP/p97 and Activates PKA to Promote NSFL1C/p47 Phosphorylation and Dendritic Arborization in Neurons |
| Q92258049 | Partial Failure of Proteostasis Systems Counteracting TDP-43 Aggregates in Neurodegenerative Diseases |
| Q38006389 | Pathogenesis of Paget disease of bone. |
| Q33815368 | Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model |
| Q37072776 | Phenotypic variability in three families with valosin-containing protein mutation. |
| Q26863702 | Potential mechanisms of progranulin-deficient FTLD |
| Q26753190 | Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease |
| Q38336025 | Prions and Protein Assemblies that Convey Biological Information in Health and Disease. |
| Q57459212 | Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice |
| Q41908673 | Progress of endocytic CHRN to autophagic degradation is regulated by RAB5-GTPase and T145 phosphorylation of SH3GLB1 at mouse neuromuscular junctions in vivo |
| Q36078240 | Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin |
| Q36224548 | Proteasomal degradation of preemptive quality control (pQC) substrates is mediated by an AIRAPL-p97 complex |
| Q36080410 | Protective role of cell division cycle 48 (CDC48) protein against neurodegeneration via ubiquitin-proteasome system dysfunction during zebrafish development |
| Q33621868 | Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities? |
| Q33653996 | Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum |
| Q30274646 | Protein interaction profiling of the p97 adaptor UBXD1 points to a role for the complex in modulating ERGIC-53 trafficking |
| Q33607616 | Protein kinase A inhibition facilitates the antitumor activity of xanthohumol, a valosin-containing protein inhibitor. |
| Q37999718 | Protein oxidation in Huntington disease. |
| Q38230383 | Protein recycling pathways in neurodegenerative diseases |
| Q36232194 | Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis. |
| Q41991266 | Proteostasis disturbance in amyotrophic lateral sclerosis |
| Q35408665 | Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy |
| Q39676193 | Quantitation of "autophagic flux" in mature skeletal muscle |
| Q91771264 | RNA Granules and Their Role in Neurodegenerative Diseases |
| Q35462835 | Rapamycin and chloroquine: the in vitro and in vivo effects of autophagy-modifying drugs show promising results in valosin containing protein multisystem proteinopathy |
| Q28119072 | Rare Manifestation of a c.290 C>T, p.Gly97Glu VCP Mutation |
| Q37371636 | Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis |
| Q37706316 | Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion |
| Q33852678 | Regulation of mitochondrial genome inheritance by autophagy and ubiquitin-proteasome system: implications for health, fitness, and fertility |
| Q38086397 | Regulation of molecular chaperones through post-translational modifications: decrypting the chaperone code |
| Q48193394 | Removing the waste bags: how p97 drives autophagy of lysosomes |
| Q28306744 | Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways |
| Q26747328 | Ring of Change: CDC48/p97 Drives Protein Dynamics at Chromatin |
| Q37107157 | Role of Epg5 in selective neurodegeneration and Vici syndrome. |
| Q36804013 | Role of p97/VCP (Cdc48) in genome stability |
| Q35149419 | Rotavirus increases levels of lipidated LC3 supporting accumulation of infectious progeny virus without inducing autophagosome formation |
| Q33738889 | SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib. |
| Q38184230 | SQSTM1 mutations--bridging Paget disease of bone and ALS/FTLD. |
| Q40698779 | SQSTM1 splice site mutation in distal myopathy with rimmed vacuoles |
| Q24337684 | SVIP induces localization of p97/VCP to the plasma and lysosomal membranes and regulates autophagy |
| Q35904083 | Selective autophagy in Drosophila |
| Q28246908 | Should I stay or should I go: VCP/p97-mediated chromatin extraction in the DNA damage response |
| Q36211432 | Slow development of ALS-like spinal cord pathology in mutant valosin-containing protein gene knock-in mice |
| Q34346014 | Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. |
| Q36099689 | Spatial expression patterns of autophagy genes in the eye lens and induction of autophagy in lens cells |
| Q48171061 | Specific mutations in the D1-D2 linker region of VCP/p97 enhance ATPase activity and confer resistance to VCP inhibitors |
| Q38767200 | Sporadic inclusion body myositis - a myodegenerative disease or an inflammatory myopathy |
| Q37776127 | Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkers |
| Q38835008 | Stress granules at the intersection of autophagy and ALS. |
| Q36677811 | Structural and functional deviations in disease-associated p97 mutants |
| Q36767612 | Structure and function of the AAA+ ATPase p97/Cdc48p |
| Q28283214 | Structure-activity relationship study reveals ML240 and ML241 as potent and selective inhibitors of p97 ATPase |
| Q36143226 | Study of Autophagy and Microangiopathy in Sural Nerves of Patients with Chronic Idiopathic Axonal Polyneuropathy |
| Q38697289 | Systemic Analysis of miRNAs in PD Stress Condition: miR-5701 Modulates Mitochondrial-Lysosomal Cross Talk to Regulate Neuronal Death |
| Q28080628 | TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets |
| Q37733168 | TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration |
| Q33932237 | TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. |
| Q49851062 | TIA1 variant drives myodegeneration in multisystem proteinopathy with SQSTM1 mutations. |
| Q36840516 | TMEM184b Promotes Axon Degeneration and Neuromuscular Junction Maintenance |
| Q35213944 | Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis |
| Q46087491 | Targeting protein quality control pathways in breast cancer |
| Q28269674 | Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis |
| Q29465536 | The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway |
| Q24314869 | The FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of lysosomes |
| Q30008982 | The Myoblast C2C12 Transfected with Mutant Valosin-Containing Protein Exhibits Delayed Stress Granule Resolution on Oxidative Stress. |
| Q64054884 | The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD |
| Q91781195 | The Peripheral Nervous System in Amyotrophic Lateral Sclerosis: Opportunities for Translational Research |
| Q92711469 | The Regulation of the Small Heat Shock Protein B8 in Misfolding Protein Diseases Causing Motoneuronal and Muscle Cell Death |
| Q33819258 | The Role of the Heat Shock Protein B8 (HSPB8) in Motoneuron Diseases. |
| Q34178673 | The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis. |
| Q34632255 | The complexities of p97 function in health and disease |
| Q37781878 | The elimination of accumulated and aggregated proteins: a role for aggrephagy in neurodegeneration |
| Q38819083 | The fine-tuning of proteolytic pathways in Alzheimer's disease |
| Q27316347 | The homozygote VCP(R¹⁵⁵H/R¹⁵⁵H) mouse model exhibits accelerated human VCP-associated disease pathology |
| Q89771533 | The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention |
| Q34344671 | The nascent polypeptide-associated complex is essential for autophagic flux. |
| Q28513793 | The p97/VCP ATPase is critical in muscle atrophy and the accelerated degradation of muscle proteins |
| Q29614834 | The role of autophagy in neurodegenerative disease |
| Q34347017 | The role of ubiquitin in autophagy-dependent protein aggregate processing |
| Q38202869 | The selectivity and specificity of autophagy in Drosophila. |
| Q33980214 | The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution |
| Q37355794 | Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS. |
| Q38078803 | Therapeutic induction of autophagy to modulate neurodegenerative disease progression |
| Q48312639 | Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone |
| Q33692936 | Tumor Suppressor RARRES1 Regulates DLG2, PP2A, VCP, EB1, and Ankrd26. |
| Q34775357 | Type 2 transglutaminase in Huntington’s disease: a double‐edged sword with clinical potential |
| Q39664260 | UBQLN2/P62 cellular recycling pathways in amyotrophic lateral sclerosis and frontotemporal dementia |
| Q38682988 | Ubiquitin- and ATP-dependent unfoldase activity of P97/VCP•NPLOC4•UFD1L is enhanced by a mutation that causes multisystem proteinopathy |
| Q92462873 | Ubiquitination is required for the initial removal of paternal organelles in C. elegans |
| Q30540665 | VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations |
| Q46040472 | VCP takes out the trash. |
| Q36071401 | VCP-dependent muscle degeneration is linked to defects in a dynamic tubular lysosomal network in vivo |
| Q30274624 | VCP/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagy |
| Q35635102 | Valosin containing protein associated fronto-temporal lobar degeneration: clinical presentation, pathologic features and pathogenesis |
| Q41028234 | Valosin-containing protein (VCP)-Adaptor Interactions are Exceptionally Dynamic and Subject to Differential Modulation by a VCP Inhibitor |
| Q58259709 | Valosin-containing protein (VCP): structure, functions, and implications in neurodegenerative diseases |
| Q37714188 | Valosin-containing protein (VCP/p97) inhibitors relieve Mitofusin-dependent mitochondrial defects due to VCP disease mutants |
| Q24306634 | Valosin-containing protein (VCP/p97) is required for poliovirus replication and is involved in cellular protein secretion pathway in poliovirus infection |
| Q35578562 | Valosin-containing protein and neurofibromin interact to regulate dendritic spine density |
| Q34890838 | Valosin-containing protein gene mutations: cellular phenotypes relevant to neurodegeneration |
| Q36714776 | Valosin-containing protein is a key mediator between autophagic cell death and apoptosis in adult hippocampal neural stem cells following insulin withdrawal |
| Q58582569 | Znf179 E3 ligase-mediated TDP-43 polyubiquitination is involved in TDP-43- ubiquitinated inclusions (UBI) (+)-related neurodegenerative pathology |
| Q86871554 | [Amyotrophic lateral sclerosis. Multisystem degeneration] |
| Q36853801 | mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy |
| Q36246261 | p62 Pathology Model in the Rat Substantia Nigra with Filamentous Inclusions and Progressive Neurodegeneration |
| Q34318246 | p97-containing complexes in proliferation control and cancer: emerging culprits or guilt by association? |
Search more.